Gregory A Gould
CIK 1252905 · Chief Financial Officer · last filed 2026-06-12
Gregory A Gould is a Chief Financial Officer who has filed 54 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for ACONW, was dated Jun 12, 2026. Current disclosed insider exposure totals $1.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.2K
4
54
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACONW | Chief Financial Officer | 50,000 | $0.02 | $1.2K | $0 | 2 | 2026-06-12 |
| NewAge, Inc. (NBEV) Delisted | Chief Financial Officer | 331,255 | $0.09 | $31.0K | $0 | 7 | 2021-07-07 |
| Ampio Pharmaceuticals, Inc. (AMPE) Delisted | Chief Financial Officer | — | $0.18 | — | $0 | 2 | 2016-07-19 |
| SERACARE LIFE SCIENCES INC (SRLS) Delisted | Interim CEO, CFO, Treas & Sec. | 0 | — | — | $0 | 17 | 2012-04-20 |
Recent Filings
54 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-12 | ACONW | Grant (A) | +50,000 | $0 | EDGAR |
| 2025-09-03 | ACONW | Grant (A) | — | $0 | EDGAR |
| 2022-06-21 | — | Grant (A) | — | $0 | |
| 2021-07-07 | NewAge, Inc. (NBEV) Delisted | Tax (F) | −73,110 | -$163.8K | EDGAR |
| 2021-03-12 | NewAge, Inc. (NBEV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-01-05 | NewAge, Inc. (NBEV) Delisted | Tax (F) | −26,507 | -$69.7K | EDGAR |
| 2020-12-11 | NewAge, Inc. (NBEV) Delisted | Tax (F) | −9,564 | -$30.2K | EDGAR |
| 2020-10-26 | NewAge, Inc. (NBEV) Delisted | Tax (F) | −9,564 | -$26.0K | EDGAR |
| 2019-12-12 | NewAge, Inc. (NBEV) Delisted | Grant (A) | +100,000 | $0 | EDGAR |
| 2019-07-03 | NewAge, Inc. (NBEV) Delisted | Grant (A) | +350,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.